Clinical Trial Update: Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR) [NA]

View source ↗

Summary

A ClinicalTrials.gov entry reports the NECTAR study evaluating neurofeedback for nociplastic pain in rheumatoid arthritis; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Widespread Pain

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Rheumatoid Arthritis, Chronic Widespread Pain | NA | Status: RECRUITING